791 related articles for article (PubMed ID: 19131155)
1. The relation of testosterone levels with fatigue and apathy in Parkinson's disease.
Kenangil G; Orken DN; Ur E; Forta H; Celik M
Clin Neurol Neurosurg; 2009 Jun; 111(5):412-4. PubMed ID: 19131155
[TBL] [Abstract][Full Text] [Related]
2. [Immune factors or depression? Fatigue correlates in Parkinson's disease].
Katsarou Z; Bostantjopoulou S; Hatzizisi O; Giza E; Soler-Cardona A; Kyriazis G
Rev Neurol; 2007 Dec 16-31; 45(12):725-8. PubMed ID: 18075986
[TBL] [Abstract][Full Text] [Related]
3. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI
Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614
[TBL] [Abstract][Full Text] [Related]
4. Clinical features of 35 patients with Parkinson's disease displaying REM behavior disorder.
Ozekmekçi S; Apaydin H; Kiliç E
Clin Neurol Neurosurg; 2005 Jun; 107(4):306-9. PubMed ID: 15885389
[TBL] [Abstract][Full Text] [Related]
5. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G
Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
[TBL] [Abstract][Full Text] [Related]
6. A multicenter, open-label, sequential study comparing preferences for carbidopa-levodopa orally disintegrating tablets and conventional tablets in subjects with Parkinson's disease.
Nausieda PA; Pfeiffer RF; Tagliati M; Kastenholz KV; DeRoche C; Slevin JT
Clin Ther; 2005 Jan; 27(1):58-63. PubMed ID: 15763606
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study.
Pedersen KF; Larsen JP; Alves G; Aarsland D
Parkinsonism Relat Disord; 2009 May; 15(4):295-9. PubMed ID: 18801696
[TBL] [Abstract][Full Text] [Related]
8. A comparison of fatigue measures in Parkinson's disease.
Grace J; Mendelsohn A; Friedman JH
Parkinsonism Relat Disord; 2007 Oct; 13(7):443-5. PubMed ID: 17055331
[TBL] [Abstract][Full Text] [Related]
9. Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
Pålhagen SE; Carlsson M; Curman E; Wålinder J; Granérus AK
Acta Neurol Scand; 2008 May; 117(5):295-304. PubMed ID: 18279483
[TBL] [Abstract][Full Text] [Related]
10. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
[TBL] [Abstract][Full Text] [Related]
11. The association between fatigue and apathy in patients with either Parkinson's disease or multiple sclerosis.
Cochrane GD; Rizvi S; Abrantes AM; Crabtree B; Cahill J; Friedman JH
Parkinsonism Relat Disord; 2015 Sep; 21(9):1093-5. PubMed ID: 26228083
[TBL] [Abstract][Full Text] [Related]
12. Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life.
Grosset KA; Grosset DG
Mov Disord; 2005 May; 20(5):616-9. PubMed ID: 15719417
[TBL] [Abstract][Full Text] [Related]
13. Bilateral impairments of skilled reach-to-eat in early Parkinson's disease patients presenting with unilateral or asymmetrical symptoms.
Doan JB; Melvin KG; Whishaw IQ; Suchowersky O
Behav Brain Res; 2008 Dec; 194(2):207-13. PubMed ID: 18692094
[TBL] [Abstract][Full Text] [Related]
14. Parkinson disease with old-age onset: a comparative study with subjects with middle-age onset.
Diederich NJ; Moore CG; Leurgans SE; Chmura TA; Goetz CG
Arch Neurol; 2003 Apr; 60(4):529-33. PubMed ID: 12707066
[TBL] [Abstract][Full Text] [Related]
15. Serum uric acid levels in patients with Parkinson's disease: their relationship to treatment and disease duration.
Andreadou E; Nikolaou C; Gournaras F; Rentzos M; Boufidou F; Tsoutsou A; Zournas C; Zissimopoulos V; Vassilopoulos D
Clin Neurol Neurosurg; 2009 Nov; 111(9):724-8. PubMed ID: 19632030
[TBL] [Abstract][Full Text] [Related]
16. Voice abnormalities and their relation with motor dysfunction in Parkinson's disease.
Midi I; Dogan M; Koseoglu M; Can G; Sehitoglu MA; Gunal DI
Acta Neurol Scand; 2008 Jan; 117(1):26-34. PubMed ID: 18031561
[TBL] [Abstract][Full Text] [Related]
17. What determines resilience in patients with Parkinson's disease?
Robottom BJ; Gruber-Baldini AL; Anderson KE; Reich SG; Fishman PS; Weiner WJ; Shulman LM
Parkinsonism Relat Disord; 2012 Feb; 18(2):174-7. PubMed ID: 21975263
[TBL] [Abstract][Full Text] [Related]
18. Validation of the Unified Parkinson's Disease Rating Scale (UPDRS) section I as a screening and diagnostic instrument for apathy in patients with Parkinson's disease.
Pedersen KF; Larsen JP; Aarsland D
Parkinsonism Relat Disord; 2008; 14(3):183-6. PubMed ID: 17889589
[TBL] [Abstract][Full Text] [Related]
19. Olfaction and apathy in Parkinson's disease.
Cramer CK; Friedman JH; Amick MM
Parkinsonism Relat Disord; 2010 Feb; 16(2):124-6. PubMed ID: 19783195
[TBL] [Abstract][Full Text] [Related]
20. Bladder symptoms assessed with overactive bladder questionnaire in Parkinson's disease.
Iacovelli E; Gilio F; Meco G; Fattapposta F; Vanacore N; Brusa L; Giacomelli E; Gabriele M; Rubino A; Locuratolo N; Iani C; Pichiorri F; Colosimo C; Carbone A; Palleschi G; Inghilleri M
Mov Disord; 2010 Jul; 25(9):1203-9. PubMed ID: 20310046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
